Poorly differentiated thyroid cancer

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 22, Issue 2, 2014, Pages 121-126

  Patel, Kepal N ^a   Shaha, Ashok R ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Diagnosis; Insular thyroid cancer; Poorly differentiated thyroid cancer; Prognosis; Thyroid cancer progression

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; INSULAR THYROID CARCINOMA; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; MULTIMODALITY CANCER THERAPY; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; THYROID CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; THYROID NEOPLASMS;

EID: 84897063253     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0000000000000037     Document Type: Review

References (48)

1. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004; 114: 393-402.
2. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983; 52: 1849-1855.
3. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ('insular') thyroid carcinoma. A reinterpretation of Langhans' 'wuchernde Struma'. Am J Surg Pathol 1984; 8: 655-668.
4. Nishida T, Katayama S, Tsujimoto M, et al. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 1999; 23: 205-211.
5. Sobrinho-Simoes M, Sambade C, Fonseca E, Soares P. Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol 2002; 10: 123-131.
6. Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007; 31: 1256-1264.
7. Langhans T. Uber die epithelialen formen der malignen struma. Virchows Arch Pathol Anat 1907; 189: 69-188.
8. Hedinger CE. Thyroid cancer. London, Berlin, New York: Heinemann Medical Springer; 1969.
9. Meissner WA, Warren S. Tumors of the thyroid gland. Washington DC: Armed Forces Institute of Pathology; 1969.
10. Woolner LB, Beahrs OH, Black BM, et al. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg 1961; 102: 354-387.
11. Hiltzik D, Carlson DL, Tuttle RM, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 2006; 106: 1286-1295.
12. Papotti M, Botto Micca F, Favero A, et al. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 1993; 17: 291-301.
13. Hannallah J, Rose J, Guerrero MA. Comprehensive literature review: recent advances in diagnosing and managing patients with poorly differentiated thyroid carcinoma. Int J Endocrinol 2013; 2013:317487.
14. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 1989; 13: 1041-1049.
15. Pilotti S, Collini P, Manzari A, et al. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 1995; 12: 249-255.
16. Sobrinho-Simoes M, Nesland JM, Johannessen JV. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 1988; 89: 264-267.
17. Akslen LA, LiVolsi VA. Poorly differentiated thyroid carcinoma: it is important. Am J Surg Pathol 2000; 24: 310-313.
18. Nikiforov YE, Erickson LA, Nikiforova MN, et al. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 2001; 25: 1478-1484.
19. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 1994; 74: 748-766.
20. Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 1996; 81: 9-14.
21. Yunta PJ, Ponce JL, Prieto M, et al. The importance of a tumor capsule in columnar cell thyroid carcinoma: a report of two cases and review of the literature. Thyroid 1999; 9: 815-819.
22. Pietribiasi F, Sapino A, Papotti M, Bussolati G. Cytologic features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fine-needle aspiration biopsy. Am J Clin Pathol 1990; 94: 687-692.
23. Patel KN, Shaha AR. Poorly differentiated and anaplastic thyroid cancer. Cancer Control 2006; 13: 119-128.
24. Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 2000; 231: 329-338.
25. Burman KD, Ringel MD, Wartofsky L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am 1996; 25: 49-68.
26. Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 2004; 86: 44-54.
27. Wreesmann VB, Ghossein RA, Patel SG, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol 2002; 161: 1549-1556.
28. Bongiovanni M, Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: a cytologic-histologic review. Adv Anat Pathol 2009; 16: 283-289.
29. Sanders EM Jr, LiVolsi VA, Brierley J, et al. An evidence-based review of poorly differentiated thyroid cancer. World J Surg 2007; 31: 934-945.
30. Chao TC, Lin JD, Chen MF. Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg 2004; 28: 393-396.
31. Volante M, Cavallo GP, Papotti M. Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid. Endocr Pathol 2004; 15: 313-317.
32. Walczyk A, Kowalska A, Sygut J. The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma): own observations. Endokrynol Pol 2010; 61: 467-473.
33. Jung TS, Kim TY, Kim KW, et al. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 2007; 54: 265-274.
34. Ibrahimpasic T, Ghossein R, Carlson DL, et al. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 memorial sloan-kettering cancer center experience. Thyroid 2013; 23: 997-1002.
35. van den Brekel MW, Hekkenberg RJ, Asa SL, et al. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 1997; 107: 254-259.
36. Ashfaq R, Vuitch F, Delgado R, Albores-Saavedra J. Papillary and follicular thyroid carcinomas with an insular component. Cancer 1994; 73: 416-423.
37. Decaussin M, Bernard MH, Adeleine P, et al. Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component. Am J Surg Pathol 2002; 26: 1007-1015.
38. Brierley JD, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 1999; 16: 42-49.
39. Asakawa H, Kobayashi T, Komoike Y, et al. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma. Anticancer Res 1997; 17: 2757-2762.
40. Wang W, Macapinlac H, Larson SM, et al. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 1999; 84: 2291-2302.
41. Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 2000; 85: 1107-1113.
42. Xing M. BRAF V600E mutation and papillary thyroid cancer. JAMA 2013; 310:535.
43. Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 2013; 309: 1493-1501.
44. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762.
45. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nature reviews. Endocrinology 2011; 7: 569-580.
46. Nikiforov YE. Genetic alterations involved in the transition from well differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 2004; 15: 319-327.
47. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008; 21 (Suppl 2):S37-S43.
48. Grande E, Diez JJ, Zafon C, Capdevila J. Thyroid cancer: molecular aspects and new therapeutic strategies. J Thyroid Res 2012; 2012:847108.